[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 2, Issue 5 (Autumn 2005) ::
Sci J Iran Blood Transfus Organ 2005, 2(5): 151-156 Back to browse issues page
A preliminary study on the effect of two therapeutic procedures on the expression of BCR-ABL gene in CML patients
Gh.R. Navidi , H. Rezvan, S. Samiei, R. Naghizadeh, A. Hajifathali, F. Soleimanlo, R. Tahernia, Sh. Esmaeilzadeh
Abstract:   (25312 Views)

  Abstract

  

 Background and Objectives

  Chronic myelogenesis leukemia (CML) is a chronic myeloproliferative disorder resulting from a specific mutation in a pluripotent stem cell. The association of philadelphia chromosome with this disorder was described in 1973. Subsequently, the BCR-ABL fusion gene and its product which is a tyrosin kinase inhibiting apoptosis were introduced. The treatment of choice for these patients is BMT as well as the new molecular treatment of imatinib mesylate. The present study was designed in order to compare the rate of expression of the BCR-ABL gene in patients who had undergone treatment by bone marrow transplantation with those treated by imatimib.

 

  Materials and Methods

  Expression of BCR-ABL gene was measured in 34 patients 17 patients were treated with BMT and 17 with imatinib mesylate using quantitative PCR on a light cycler instrument.

  

 Results

  The results obtained in this preliminary study demonstrates that rate of gene expression in patients treated with imatinib mesylate for more than 8 months was similar to that found in patients treated with BMT who were in relatively stable conditions.

 

 Conclusions

  This finding may be an indication that imatinib mesylate as a molecular inhibitor can have the same effect as BMT but with less adverse effects. Clearly, definite conclusions require more extensive studies on larger number of patients.

  

  

 Key words: Gleevec®, Imatinib Mesylate, CML, BCR-ABL, Bone Marrow Transplantation, CML

Keywords: Gleevec®, Imatinib Mesylate, CML, BCR-ABL, Bone Marrow Transplantation, CML
Full-Text [PDF 171 kb]   (6209 Downloads)    
Type of Study: Research | Subject: General
Published: 2014/06/30
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Navidi G, Rezvan H, Samiei S, Naghizadeh R, Hajifathali A, Soleimanlo F, et al . A preliminary study on the effect of two therapeutic procedures on the expression of BCR-ABL gene in CML patients. Sci J Iran Blood Transfus Organ. 2005; 2 (5) :151-156
URL: http://bloodjournal.ir/article-1-39-en.html


Volume 2, Issue 5 (Autumn 2005) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4312